CONTRAVISORY INVESTMENT MANAGEMENT, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
CONTRAVISORY INVESTMENT MANAGEMENT, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$292,479
+6.4%
3,265
+1.1%
0.08%
+13.7%
Q2 2023$274,832
+2.9%
3,2280.0%0.07%
-2.7%
Q1 2023$267,117
+4092.7%
3,228
+3885.2%
0.08%
+3650.0%
Q4 2022$6,371
+6.2%
810.0%0.00%0.0%
Q3 2022$6,000
+20.0%
810.0%0.00%0.0%
Q2 2022$5,000
-97.2%
81
-98.5%
0.00%
-95.2%
Q3 2015$178,000
-21.6%
5,5000.0%0.04%
-14.3%
Q2 2015$227,000
-8.1%
5,5000.0%0.05%
-2.0%
Q1 2015$247,0005,5000.05%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders